Cargando…

A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex

BACKGROUND: The use of anti-B cell based therapies in immune-mediated diseases targeting general B cell markers or molecules important for B cell function has increased the clinical needs of monitoring B cell subpopulations. RESULTS: We analyzed the expression profile of cell surface markers CD86 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Axelsson, Susanne, Magnuson, Anders, Lange, Anna, Alshamari, Aseel, Hörnquist, Elisabeth Hultgren, Hultgren, Olof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082969/ https://www.ncbi.nlm.nih.gov/pubmed/32197584 http://dx.doi.org/10.1186/s12865-020-00343-2

Ejemplares similares

Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells
por: Günaltay, Sezin, et al.
Publicado: (2017)

Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
por: Lange, Anna, et al.
Publicado: (2017)

Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis
por: Lange, Anna, et al.
Publicado: (2022)

An In Vitro Model to Evaluate the Impact of the Soluble Factors from the Colonic Mucosa of Collagenous Colitis Patients on T Cells: Enhanced Production of IL-17A and IL-10 from Peripheral CD4(+) T Cells
por: Kumawat, Ashok Kumar, et al.
Publicado: (2014)

Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment
por: Günaltay, Sezin, et al.
Publicado: (2015)

Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls
por: Lushnikova, Alexandra, et al.
Publicado: (2021)

A Quantitative Study of the Mechanisms behind Thymic Atrophy in Gαi2-Deficient Mice during Colitis Development
por: Elgbratt, Kristina, et al.
Publicado: (2012)

CD4(+)FoxP3(+) Regulatory T Cells from Gαi2(−/−) Mice Are Functionally Active In Vitro, but Do Not Prevent Colitis
por: Götlind, Yu-Yuan C., et al.
Publicado: (2011)

Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
por: Günaltay, Sezin, et al.
Publicado: (2017)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration
por: Hultgren, Olof H, et al.
Publicado: (2001)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD
por: Bergemalm, Daniel, et al.
Publicado: (2017)

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
por: Gerasimova, Elena V., et al.
Publicado: (2022)

Reduced T Cell Receptor Excision Circle Levels in the Colonic Mucosa of Microscopic Colitis Patients Indicate Local Proliferation rather than Homing of Peripheral Lymphocytes to the Inflamed Mucosa
por: Kumawat, Ashok Kumar, et al.
Publicado: (2013)

Diagnosis and management of microscopic colitis: current perspectives
por: Bohr, Johan, et al.
Publicado: (2014)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
por: Karabon, L., et al.
Publicado: (2020)

BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
por: Yu, Xueping, et al.
Publicado: (2019)

The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis
por: Cai, Xue-Qian, et al.
Publicado: (2023)

Single-cell analysis identifies cellular markers of the HIV permissive cell
por: Rato, Sylvie, et al.
Publicado: (2017)

Roles of BTLA in Immunity and Immune Disorders
por: Ning, Zhaochen, et al.
Publicado: (2021)

The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota
por: Kou, Yanbo, et al.
Publicado: (2022)

BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine
por: Kannan, Senthil, et al.
Publicado: (2015)

Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis
por: Hultgren, Olof H, et al.
Publicado: (2001)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)

Contrasting amino acid profiles among permissive and non-permissive hosts of Candidatus Liberibacter asiaticus, putative causal agent of Huanglongbing
por: Sétamou, Mamoudou, et al.
Publicado: (2017)

Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
por: Albring, Jörn C., et al.
Publicado: (2010)

Clinical significance of tumor‐infiltrating immune cells focusing on BTLA and Cbl‐b in patients with gallbladder cancer
por: Oguro, Seiji, et al.
Publicado: (2015)

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types
por: Wu, Yuliang, et al.
Publicado: (2022)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
por: Karabon, Lidia, et al.
Publicado: (2021)

Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis
por: Trzupek, Dominik, et al.
Publicado: (2020)

BTLA as a biomarker and mediator of sepsis-induced immunosuppression
por: Sherwood, Edward R, et al.
Publicado: (2013)

Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding
por: Spodzieja, Marta, et al.
Publicado: (2020)

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
por: Choi, John, et al.
Publicado: (2021)

Change in Exercise Performance and Markers of Acute Kidney Injury Following Heat Acclimation with Permissive Dehydration
por: Haroutounian, Arpie, et al.
Publicado: (2021)

ADAM 12: A Putative Marker of Oligodendrogliomas?
por: Kanakis, Dimitrios, et al.
Publicado: (2013)

B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity
por: Piancone, Federica, et al.
Publicado: (2016)

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia
por: Karabon, Lidia, et al.
Publicado: (2016)

A crucial role for HVEM and BTLA in preventing intestinal inflammation
por: Steinberg, Marcos W., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0fje3eano8kiot1n2ec0q0jeao